These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 14505244)

  • 1. Topiramate for patients with refractory migraine: an observational, multicenter study in Spain.
    Pascual J; Sánchez del Rio M; Mateos V; Láinez JM; Hernández-Gallego J; Leira R; Jiménez MD
    Neurologia; 2003 Sep; 18(7):364-7. PubMed ID: 14505244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
    Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
    Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing the combination beta-blocker plus topiramate in refractory migraine.
    Pascual J; Rivas MT; Leira R
    Acta Neurol Scand; 2007 Feb; 115(2):81-3. PubMed ID: 17212609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.
    Limmroth V; Biondi D; Pfeil J; Schwalen S
    Headache; 2007 Jan; 47(1):13-21. PubMed ID: 17355489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topiramate in the prophylactic treatment of migraine in children.
    Campistol J; Campos J; Casas C; Herranz JL
    J Child Neurol; 2005 Mar; 20(3):251-3. PubMed ID: 15832623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis.
    Luo N; Di W; Zhang A; Wang Y; Ding M; Qi W; Zhu Y; Massing MW; Fang Y
    Pain Med; 2012 Jan; 13(1):80-6. PubMed ID: 22233396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of topiramate on health-related quality of life indicators in chronic migraine.
    Dodick DW; Silberstein S; Saper J; Freitag FG; Cady RK; Rapoport AM; Mathew NT; Hulihan J; Crivera C; Rupnow MF; Mao L; Finlayson G; Greenberg SJ
    Headache; 2007; 47(10):1398-408. PubMed ID: 18052949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.
    Winner P; Pearlman EM; Linder SL; Jordan DM; Fisher AC; Hulihan J;
    Headache; 2005; 45(10):1304-12. PubMed ID: 16324162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate in migraine prevention: evidence-based medicine from clinical trials.
    Silberstein SD
    Neurol Sci; 2004 Oct; 25 Suppl 3():S244-5. PubMed ID: 15549548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.
    Bussone G; Diener HC; Pfeil J; Schwalen S
    Int J Clin Pract; 2005 Aug; 59(8):961-8. PubMed ID: 16033621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
    Seeburger JL; Cady RK; Winner P; MacGregor A; Valade D; Ge Y; Zhang Y; Hustad CM; Strickler N; Schaefer E; Connor KM; Ho TW
    Headache; 2012 Jan; 52(1):57-67. PubMed ID: 22078129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term migraine prevention with topiramate: open-label extension of pivotal trials.
    Rapoport A; Mauskop A; Diener HC; Schwalen S; Pfeil J
    Headache; 2006; 46(7):1151-60. PubMed ID: 16866719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate for migraine prevention in a naturalistic setting: results from an open label, flexible dose study.
    Nelles G; Delbrück A; Schulze L; Kademann B; Bornhoevd K; Schäfer S; Schäuble B;
    Headache; 2009; 49(10):1454-65. PubMed ID: 19804392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of a negative response to topiramate therapy in patients with chronic migraine.
    Rothrock JF; Parada VA; Drinkard R; Zweifler RM; Key KF
    Headache; 2005; 45(7):932-5. PubMed ID: 15985112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate intervention to prevent transformation of episodic migraine: the topiramate INTREPID study.
    Lipton RB; Silberstein S; Dodick D; Cady R; Freitag F; Mathew N; Biondi DM; Ascher S; Olson WH; Hulihan J
    Cephalalgia; 2011 Jan; 31(1):18-30. PubMed ID: 20974598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV; Jevoux CC
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).
    Gupta P; Singh S; Goyal V; Shukla G; Behari M
    Headache; 2007 Mar; 47(3):402-12. PubMed ID: 17371357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate in migraine prevention.
    Silberstein SD
    Headache; 2005 Apr; 45 Suppl 1():S57-65. PubMed ID: 15833091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.